Plasma PCSK9 level is unrelated to blood pressure and not associated independently with carotid intima–media thickness in hypertensives
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma PCSK9 level is unrelated to blood pressure and not associated independently with carotid intima–media thickness in hypertensives
Authors
Keywords
-
Journal
HYPERTENSION RESEARCH
Volume 39, Issue 8, Pages 598-605
Publisher
Springer Nature
Online
2016-04-14
DOI
10.1038/hr.2016.38
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease
- (2015) Sha Li et al. ANNALS OF MEDICINE
- Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary PreventionSignificance
- (2015) Yiming M. Zhu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension
- (2015) Jean-Mathieu Berger et al. ATHEROSCLEROSIS
- Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials
- (2015) A. Sahebkar et al. DIABETES OBESITY & METABOLISM
- Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events
- (2015) Paul M. Ridker et al. EUROPEAN HEART JOURNAL
- Carotid intima-media thickness and elastic properties of aortas in normotensive children of hypertensive parents
- (2015) Ali Yildirim et al. HYPERTENSION RESEARCH
- PCSK9 variation and association with blood pressure in African Americans: preliminary findings from the HyperGEN and REGARDS studies
- (2015) Ngan T. Tran et al. Frontiers in Genetics
- Rate of control of LDL cholesterol and incident hypertension requiring antihypertensive treatment in hypercholesterolemic subjects in daily clinical practice
- (2014) Claudio Borghi et al. ANNALS OF MEDICINE
- Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
- (2014) Sha Li et al. ATHEROSCLEROSIS
- PCSK9
- (2014) Nabil G. Seidah et al. CIRCULATION RESEARCH
- PCSK9 and LDLR degradation
- (2014) Thomas A. Lagace CURRENT OPINION IN LIPIDOLOGY
- Serum LDL cholesterol levels and new onset of arterial hypertension: an 8-year follow-up
- (2014) Arrigo F.G. Cicero et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Serial assessment of arterial stiffness by cardio-ankle vascular index for prediction of future cardiovascular events in patients with coronary artery disease
- (2014) Kenichiro Otsuka et al. HYPERTENSION RESEARCH
- Five-year change in systolic blood pressure is independently associated with carotid atherosclerosis progression: a population-based cohort study
- (2014) Wuxiang Xie et al. HYPERTENSION RESEARCH
- Arterial stiffness estimation in healthy subjects: a validation of oscillometric (Arteriograph) and tonometric (SphygmoCor) techniques
- (2014) Margareta Ring et al. HYPERTENSION RESEARCH
- Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease
- (2014) Yan Zhang et al. Journal of Clinical Lipidology
- Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
- (2014) Rui-Xia Xu et al. Lipids in Health and Disease
- Diabetic dyslipidemia
- (2014) Liya Wu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
- (2014) Dirk J. Blom et al. NEW ENGLAND JOURNAL OF MEDICINE
- AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy
- (2013) Nihar R. Desai et al. CIRCULATION
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) EUROPEAN HEART JOURNAL
- Positive effects of antihypertensive treatment on aortic stiffness in the general population
- (2013) Jitka Seidlerová et al. HYPERTENSION RESEARCH
- Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
- (2013) Daniel Urban et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of serum proprotein convertase subtilisin/kexin type 9 with carotid intima media thickness in hypertensive subjects
- (2013) Chan Joo Lee et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets
- (2013) Bertrand Cariou et al. Nutrition & Metabolism
- Interactions of Several Lipid-Related Gene Polymorphisms and Cigarette Smoking on Blood Pressure Levels
- (2012) Rui-Xing Yin et al. International Journal of Biological Sciences
- Regulation of Epithelial Sodium Channel Trafficking by Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
- (2012) Vikas Sharotri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study
- (2011) M.C.G.J. Brouwers et al. ATHEROSCLEROSIS
- Clinical aspects of PCSK9
- (2011) Bertrand Cariou et al. ATHEROSCLEROSIS
- Lipoprotein Subclass Abnormalities and Incident Hypertension in Initially Healthy Women
- (2011) N. P. Paynter et al. CLINICAL CHEMISTRY
- Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events
- (2011) W. Xie et al. HEART
- Association between plasma PCSK9 and gamma-glutamyl transferase levels in diabetic patients
- (2010) Bertrand Cariou et al. ATHEROSCLEROSIS
- Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population
- (2010) Qin Cui et al. ATHEROSCLEROSIS
- Effects of β-blockers on glucose and lipid metabolism
- (2010) Vivian A. Fonseca CURRENT MEDICAL RESEARCH AND OPINION
- PCSK9 Dominant Negative Mutant Results in Increased LDL Catabolic Rate and Familial Hypobetalipoproteinemia
- (2009) Bertrand Cariou et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genetic and Metabolic Determinants of Plasma PCSK9 Levels
- (2009) Susan G. Lakoski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cross-sectional and longitudinal association of cigarette smoking with carotid atherosclerosis in Chinese adults
- (2009) Li-Rong Liang et al. PREVENTIVE MEDICINE
- Plasma PCSK9 Concentrations Correlate with LDL and Total Cholesterol in Diabetic Patients and Are Decreased by Fenofibrate Treatment
- (2008) G. Lambert et al. CLINICAL CHEMISTRY
- Dyslipidaemia as a predictor of hypertension in middle-aged men
- (2008) D. E. Laaksonen et al. EUROPEAN HEART JOURNAL
- The Evidence for Dietary Prevention and Treatment of Cardiovascular Disease
- (2008) Linda Van Horn et al. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now